Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GSK
Pharma
Big Pharma bets big on MASH with a new combo playbook
GSK, Roche and Novo jumped into MASH with a multibillion-dollar deal spree. Now, the phase 3 data have to deliver.
Ayla Ellison
Oct 17, 2025 9:30am
Scynexis secures $22M payout from GSK after trial dispute
Oct 15, 2025 11:25am
GSK touts study showing tolerability edge for its long-acting PrEP
Oct 15, 2025 8:45am
Fierce Biotech
As 2 CEOs depart, life sciences face leadership void for women
Oct 3, 2025 11:22am
GSK overturns PMCPA's most serious sanction in COVID release row
Oct 3, 2025 9:45am
A whirlwind week for pharma
Oct 3, 2025 9:00am
